Latest filing published 10 Aug 2026 for Aptevo Therapeutics Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -50.1%Entry US$6,974,352.00 · Close at T+365 US$3,481,315.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zsolt Harsanyi: trading record in brief
Zsolt Harsanyi, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Emergent BioSolutions Inc. and Aptevo Therapeutics Inc. In total, 119 filings cover trades dated from 10 June 2009 to 6 August 2026.
Both buying and selling appear: 1 purchase worth €35k, against 74 sales worth €5.0M. The net balance comes to €4.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 16 share grants and 25 option exercises.
Most recently, on 10 August 2026, the filings show an option exercise in Aptevo Therapeutics Inc. The latest purchase dates back some time: it was published 2,711 days ago, on 7 June 2019. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Zsolt Harsanyi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 sharesCommon StockSEC:0001193125-26-343080:0
- 1 sharesCommon StockSEC:0000950170-25-097283:0
- 34,403 shares0Common StockSEC:0001367644-25-000105:0
- 81 sharesCommon StockSEC:0000950170-24-068073:1
- 7 sharesCommon StockSEC:0000950170-24-068073:0
- 17,430 shares0Common StockSEC:0001367644-24-000078:0
- 3,571 sharesCommon StockSEC:0001209191-23-045301:0
- 297 sharesCommon StockSEC:0001209191-23-033828:0
- 33,847 shares0Common StockSEC:0001367644-23-000104:0
- 298 sharesCommon StockSEC:0001209191-22-033930:0
- 8,446 shares0Common StockSEC:0001367644-22-000094:0
- 5,027 shares0Common StockSEC:0001367644-21-000093:0
- 6,609 shares@ US$133.7143.3% of flowCommon StockSEC:0001367644-20-000136:0
- 2,821 shares0Common StockSEC:0001367644-20-000072:0
- 3,434 shares@ US$18.643.4% of flowCommon StockSEC:0001367644-20-000068:0
- 4,940 shares@ US$81.9921.8% of flowCommon StockSEC:0001367644-20-000063:0
- 6,400 shares@ US$65.0021.7% of flowCommon StockSEC:0001367644-20-000031:0
- 3,435 shares@ US$55.007.7% of flowCommon StockSEC:0001367644-20-000004:0
- 50,000 shares@ US$0.78100.0% of flowCommon StockSEC:0001593968-19-001344:0Canonical exit: 5 Sept 2019 (T+90)
- 5,736 shares0Common StockSEC:0001567619-19-012274:0
- 8,000 shares@ US$68.9021.9% of flowCommon StockSEC:0001567619-18-005431:0
- 4,895 shares0Common StockSEC:0001140361-18-025560:0
- 7,000 shares@ US$42.476.8% of flowCommon StockSEC:0001140361-17-045556:0
- 152 shares0Common StockSEC:0001140361-17-022490:0
- 604 shares0Common StockSEC:0001140361-17-022490:1
25 of 118 declarations
